Pacira BioSciences, Inc. (PCRX)Siren, L.L.C. exited its position 225K shares
Siren, L.L.C. exited its position in Pacira BioSciences, Inc., per its Q3 2025 13F.
- 225K
- Prior-quarter shares · no longer reported
- Holdings as of
- Sep 30, 2025
- Filed
- Nov 13, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
What came next
- Jan 8, 2026Company filing · Form 8-K · ResultsReported its results
- Jan 27, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On January 27, 2026, the Board of Directors (the “Board”) of Pacira BioSciences, Inc. (the “Company”), pursuant to the Amended and Restated Certificate of Incorporation of the Company and the Third Amended and Restated Bylaws of the Company, approved an increase of the size of the Board from nine directors to 10 directors, and appointed Dr. Samit Hirawat to the Board, to serve as a Class III director, effective…”
- Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Pacira BioSciences, Inc.
For Pacira BioSciences, Inc., OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PCRX page.
How this filing works
Other disclosures at Pacira BioSciences, Inc.
- SEC Form 4Oct 9, 2026
- SEC Form 144Oct 8, 2026
- SEC Form 4Sep 8, 2025
- SEC Form 13F-HRAug 13, 2025
- SEC Form 4Aug 11, 2025
- SEC Form 4Jun 5, 2025
Everything OQRO holds on this company is on its PCRX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data